drugset / Trial / NCT01510535

Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

NCT01510535

Phase 3 Completed 287 enrolled LG Life Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare efficacy and safety of intra-articular LBSA0103 once versus intra-articular hyaluronic acid injections (Hyruan Plus Injection) once weekly for 3 weeks in the treatment of patients with osteoarthritis of the knee.

Timeline

Start
2011-12
Primary completion
2012-03
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject LBSA0103 Unknown 60 mg Other
Comparator Sodium Hyaluronate Other / unclassified 2 ml Other

Indications